Table 3 Recurrence pattern according to neoadjuvant treatment according to treatment prior to surgery for patients with LARC (N=332)
Pathological stage | Neoadjuvant treatment | |||
|---|---|---|---|---|
Surgery alone (N=232) | nCRT (N=51) | NAC (N=49) | ||
Stage 0-I | Overall | 2.0% (1/50) | 10.0% (2/20) | 15.4% (2/13) |
Local-only | 2.0% (1) | 0.0% (0) | 0.0% (0) | |
Distant-only | 0.0% (0) | 10.0% (2) | 7.7% (1) | |
Simultaneous | 0.0% (0) | 0.0% (0) | 7.7% (1) | |
Stage II | Overall | 20.2% (18/89) | 31.8% (7/22) | 22.2% (4/18) |
Local-only | 3.4% (3) | 0.0% (0) | 11.1% (2) | |
Distant-only | 14.6% (13) | 27.3% (6) | 11.1% (2) | |
Simultaneous | 2.3% (2) | 4.6% (1) | 0.0% (0) | |
Stage III | Overall | 37.6% (35/93) | 22.2% (2/9) | 38.9% (7/18) |
Local-only | 9.7% (9) | 0.0% (0) | 22.2% (4) | |
Distant-only | 22.6% (21) | 22.2% (2) | 5.7% (1) | |
Simultaneous | 5.4% (5) | 0.0% (0) | 11.1% (2) | |